Many Canadian medical societies and specially focused disease groups fail to disclose industry funding in their clinical practice guidelines, a new analysis finds. Moreover, most of the organizations included conflict-of-interest statements in their guidelines, but also had a panel member with a conflict.
Of 21 organizations that issued practice guidelines between 2016 and 2018, three reported they did not receive industry funding and all were sponsored by the Canadian government. In addition, none of their guidelines committee members disclosed a financial conflict of interest, according to the analysis in CMAJ, a journal published by the Canadian Medical Association.
About the Author Reprints
Hey Ed,
Does Canada have anything similar yo the US Sunshine Act? Just curious. It’s the easiest and quickest way to assess financial tie between a drug company and any physician, regardless of whether he or she is a member of the editorial board or guideline drafting group.